pI: 8.1536 |
Length (AA): 311 |
MW (Da): 34719 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 309 | 5exk (A) | 4 | 309 | 99.99 | 0 | 1 | 2.24082 | -1.63 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase. | hasan |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Dormant phase. | murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_127348)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G20860 | lipoic acid synthase 1 |
Arabidopsis thaliana | AT5G08415 | lipoyl synthase |
Brugia malayi | Bm1_23910 | lipoic acid synthetase, mitochondrial precursor, putative |
Candida albicans | CaO19.10290 | similar to S. cerevisiae LIP5, mitochondrial lipoate synthase |
Candida albicans | CaO19.2774 | similar to S. cerevisiae LIP5, mitochondrial lipoate synthase |
Caenorhabditis elegans | CELE_M01F1.3 | Protein M01F1.3 |
Chlamydia trachomatis | CT_558 | lipoate synthetase |
Drosophila melanogaster | Dmel_CG5231 | Lipoic acid synthase |
Escherichia coli | b0628 | lipoate synthase |
Echinococcus granulosus | EgrG_001034820 | lipoyl synthase, mitochondrial |
Echinococcus multilocularis | EmuJ_001034820 | lipoyl synthase, mitochondrial |
Homo sapiens | ENSG00000121897 | lipoic acid synthetase |
Leishmania braziliensis | LbrM.19.0670 | lipoic acid synthetase, mitochondrial precursor, putative |
Leishmania donovani | LdBPK_190350.1 | lipoic acid synthetase, mitochondrial precursor, putative |
Leishmania infantum | LinJ.19.0350 | lipoic acid synthetase, mitochondrial precursor, putative |
Leishmania major | LmjF.19.0350 | lipoic acid synthetase, mitochondrial precursor, putative |
Leishmania mexicana | LmxM.19.0350 | lipoic acid synthetase, mitochondrial precursor, putative |
Loa Loa (eye worm) | LOAG_04019 | lipoic acid synthetase |
Mycobacterium leprae | ML0858c | Probable lipoate biosynthesis protein A LipA |
Mus musculus | ENSMUSG00000029199 | lipoic acid synthetase |
Mycobacterium tuberculosis | Rv2218 | Probable lipoate biosynthesis protein A LipA |
Mycobacterium ulcerans | MUL_1343 | lipoyl synthase |
Neospora caninum | NCLIV_046560 | Lipoic acid synthetase, related |
Oryza sativa | 4336023 | Os04g0455800 |
Oryza sativa | 4339289 | Os05g0511500 |
Oryza sativa | 4325595 | Os01g0769100 |
Onchocerca volvulus | OVOC7524 | Lipoyl synthase, mitochondrial homolog |
Plasmodium berghei | PBANKA_1357500 | lipoyl synthase |
Plasmodium falciparum | PF3D7_1344600 | lipoyl synthase |
Plasmodium knowlesi | PKNH_1256700 | lipoyl synthase, putative |
Plasmodium vivax | PVX_083125 | lipoyl synthase, putative |
Plasmodium yoelii | PY06208 | lipoic acid synthetase, putative |
Saccharomyces cerevisiae | YOR196C | putative lipoate synthase |
Schistosoma japonicum | Sjp_0302390 | ko:K03644 lipoic acid synthetase, putative |
Schistosoma japonicum | Sjp_0092580 | IPR003698,Lipoate synthase,domain-containing |
Schistosoma mansoni | Smp_010100 | lipoic acid synthetase |
Schmidtea mediterranea | mk4.002599.02 | Lipoyl synthase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.10.18270 | lipoic acid synthetase, mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.10.15010 | lipoic acid synthetase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.511291.30 | lipoic acid synthetase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.506211.10 | lipoic acid synthetase, mitochondrial precursor, putative |
Toxoplasma gondii | TGME49_226400 | lipoic acid synthase LIPA |
Wolbachia endosymbiont of Brugia malayi | Wbm0303 | lipoyl synthase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2252 this record | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.10.15010 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.15010 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.15010 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.15010 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0628 | Escherichia coli | essential | goodall |
CELE_M01F1.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_M01F1.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_M01F1.3 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_1357500 | Plasmodium berghei | Dispensable | plasmo |
TGME49_226400 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.